Furthermore, sFlt-1/PlGF levels were normal among the women in the COVID-19 during pregnancy cohort of this study, which represents an important difference to other studies, which reported an increased risk of preeclampsia after COVID-19 [17,18]. The gene discussed is PGF; the disease is COVID-19.